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Abstract
Background: Cerebral ischemia/reperfusion injury is a common secondary effect of cardiac arrest which is largely 
responsible for postresuscitative mortality. Therefore development of therapies which restore and protect the brain 
function after cardiac arrest is essential. Methylene blue (MB) has been experimentally proven neuroprotective in a 
porcine model of global ischemia-reperfusion in experimental cardiac arrest. However, no comprehensive analyses 
have been conducted at gene expression level.
Methods: Pigs underwent either untreated cardiac arrest (CA) or CA with subsequent cardiopulmonary resuscitation 
(CPR) accompanied with an infusion of saline or an infusion of saline with MB. Genome-wide transcriptional profiling 
using the Affymetrix porcine microarray was performed to 1) gain understanding of delayed neuronal death initiation 
in porcine brain during ischemia and after 30, 60 and 180 min following reperfusion, and 2) identify the mechanisms 
behind the neuroprotective effect of MB after ischemic injury (at 30, 60 and 180 min).
Results: Our results show that restoration of spontaneous circulation (ROSC) induces major transcriptional changes 
related to stress response, inflammation, apoptosis and even cytoprotection. In contrast, the untreated ischemic and 
anoxic insult affected only few genes mainly involved in intra-/extracellular ionic balance. Furthermore, our data show 
that the neuroprotective role of MB is diverse and fulfilled by regulation of the expression of soluble guanylate cyclase 
and biological processes accountable for inhibition of apoptosis, modulation of stress response, neurogenesis and 
neuroprotection.
Conclusions: Our results support that MB could be a valuable intervention and should be investigated as a therapeutic 
agent against neural damage associated with I/R injury induced by cardiac arrest.
Background
Despite recent advances in out-of-hospital cardiac arrest
(CA) resuscitation, hypoxic-ischemic brain damage still
causes considerable mortality and morbidity. Of the
patients who survive to discharge, only 20% or fewer will
have good neurologic function at the end of 1 year [1]
After successful CPR and restoration of spontaneous cir-
culation (ROSC) neuronal death initiated by ischemia
during CA is increased also during reperfusion leading to
secondary postischemic-anoxic encephalopathy [2], part
of the so-called postresuscitation syndrome [3,4]. Cere-
bral recovery is dependent on duration of arrest and car-
diopulmonary resuscitation (CPR), and numerous factors
related to basic, advanced, and prolonged life support
[5,6]. Except for the use of mild hypothermia after ven-
tricular fibrillation cardiac arrest, currently recom-
mended therapy in the 2005 guidelines of the European
Resuscitation Council [7], clinical neuroprotection prac-
tice rests solely on extrapolation from animal experimen-
tal work or weak clinical studies[8]. In recent years,
especially in critical care research, swine have increas-
ingly been employed because they share similar cardio-
vascular and physiologic properties with humans [9,10].
Furthermore, porcine brains, like human, are gyrenceph-
alic which make them closely related to the human brain
in structure and function. Accordingly, the response of
pigs to disease and treatment are often comparable to
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that of human [11] and data concerning pig brain anat-
omy and neurochemistry have increased considerably in
recent years [12,13].
Safety/FDA approved methylene Blue (MB), a cationic
thiazine dye with a low toxicity profile at low doses, is
efficiently trapped in the brain and its concentration is
over 10 times higher in the brain than in the circulation
one hour after systemic administration [14], indicating a
rapid and extensive accumulation in the nervous system.
MB has been used as a neuroprotective agent in drug-
induced encephalopathy, dementia and manic-depressive
psychosis [15-17]. Furthermore, MB exhibits promising
cardio- and neuroprotective properties in experimental
cardiac arrest [18,19] and is effective in both attenuating
ischemia-reperfusion (I/R) syndrome [20] and increasing
short-term survival after resuscitation from cardiac arrest
[21].
In order to gain further understanding of the mecha-
nisms behind the neuroprotective effects of MB, we con-
ducted a microarray analysis of the changes in gene
expression in the ischemic brain in our pig model of
experimental cardiac arrest and subsequent ischemia-
reperfusion injury.
Methods
Animal treatment and experimental procedures were
approved by the Uppsala Institutional Review Board for
Animal Experimentation. The piglets were handled
according to the guidelines of the Swedish National
Board for Laboratory Animals and the European Conven-
tion of Animal Care. Anaesthesia was used in all surgical
interventions.
Animals
Experiments were performed on 30 piglets of Swedish tri-
ple breed of both sexes aged 12-14 weeks and with a
mean weight of 25.8 kg ± 1.3 kg.
Cardiac arrest model
Previous use of the same model of extended cardiac
arrest (12 min of untreated cardiac arrest (CA) and 8 min
of cardiopulmonary resuscitation (CPR) has already been
described [19]. Here we used the same anaesthesia, fluid
administration surgical preparation and experimental
protocol to induce CA. Return of spontaneous circulation
and post-resuscitative treatments either with normal
saline or with MB were administered following the proto-
col previously described by our group [18]. After comple-
tion of study, all animals received an injection of 10 mL
potassium chloride 20 mmol/mL and were sacrificed. In
all the animals the skull was opened in prone position
immediately before death and the brain was taken out
and frozen in liquid nitrogen within 1 min after death.
Thirty pigs were divided into three groups. The first
group (CA, n = 12) underwent untreated CA. The brain
of the animals was removed either immediately after CA
(Ca0 n = 3), or after 5 min (Ca5 n = 3), 20 min (Ca20 n =
3) and 30 min (Ca30 n = 3) respectively (Figure 1A). The
other two groups underwent CA followed by CPR and
r eceived eit her an infusion saline (R OSC n = 9) or an
infusion of MB (10 mg/mL Metyltioninklorid, Apoteket,
Umeå, Sweden) with saline (MB n = 9) as described in
Figure 1B. Brain samples from resuscitated animals were
collected at 30 min (Rosc30 and MB30 groups), 60 min
(Rosc60 and MB60 groups) or 180 min (Rosc180 and
MB180 groups) after ROSC.
RNA extraction
Total RNA was extracted using RNeasy Lipid Tissue kit
(Qiagen)according to the manufacturer's instructions.
Contaminating genomic DNA was removed during RNA
purification by addition of an on-column DNase diges-
tion step with RNase-Free Dnase I (Qiagen). RNA quality
was verified on an Agilent 2100 Bioanalyzer (Agilent).
Affymetrix gene profiling and microarray analysis
Total RNA (10 μg) was first converted to double-stranded
cDNA (One-cycle cDNA synthesis kit, Affymetrix UK
Ltd) and then to biotinylated cRNA (IVT labelling kit,
Affymetrix UK Ltd) as described in the One-cycle Target
Labelling protocol (Affymetrix UK Ltd). After fragmenta-
tion and quality confirmation (Agilent 2100 Bioanalyzer),
10 μg of the biotinylated cRNA were hybridized for 16
hours to an Affymetrix GeneChip Porcine Genome
Array. The array was then washed and stained with
streptavidin-phycoerythrin solution using the Fluidics
Station 450 (Affymetrix UK Ltd.) before it was scanned
using the Affymetrix GeneChip Scanner 3000. Data were
normalized and comparative analysis results were
obtained from Affymetrix GeneChip Operating Software
(GCOS v1.4; Affymetrix UK Ltd). The results were
deposited to GEO database under accession number
GSE22165. Statistical analysis was performed using the
Significance Analysis of Microarrays (SAM) statistics
program to determine genes that were significantly regu-
lated at each time point [22]. SAM uses a permutation
method to determine the significance of changes in
expression by assimilating a set of gene-specific t-tests
and hence reports a false-discovery rate (FDR) rather
than a probability. Data query, mining, filtering and sort-
ing as well as hierarchical cluster analysis and principle
component analysis (PCA) were performed using Spot-
fire DecisionSite®  for Functional Genomics software
(Tibco-Spotfire Inc., Cambridge, MA, USA).
Gene filtering and selection
In a first step, after normalization, results from the
GeneChip Operating Software (GCOS) were considered.Martijn and Wiklund BMC Medical Genomics 2010, 3:27
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Genes with raw intensity values that did not meet a mini-
mum threshold (more than 30 in at least one of the sam-
ples) or described as absent in all 30 samples were
excluded from the results. The selected probe sets were
then submitted to statistical analysis to identify signifi-
cant changes in gene expression. Pair-wise comparison
analysis based on GCOS statistical algorithm was carried
out to compare animals of the experimental group to
each animal of the corresponding control group. The
group means were also compared using the SAM soft-
ware. By combining these 2 approaches, we obtained a
list of modulated genes for each condition. The stringent
criteria for the lists of genes were that the FDR values
obtained with the SAM software were inferior to 5% and
there were 9 significant change calls generated by GCOS.
Furthermore, the lists of genes were restricted to include
only genes for which expression changes were ≥ ± 1.5-
fold. Changes which occurred 5, 20 or 30 min after car-
diac arrest or 30, 60 or 180 min after ROSC were analyzed
using the Ca0 as control group. Changes after 30, 60 or
180 min of MB treatment following ROSC were analyzed
using the Rosc30, Rosc60 and Rosc180 as control groups,
respectively.
Confirmatory Real-Time PCR analysis
Data generated from microarrays were confirmed using
real-time PCR (qPCR).
RNA was extracted as described above and then was
reversely transcribed using oligo(dT) and random hex-
Figure 1 Experimental procedure. After stabilization for 1 h, animals were subjected to ventricular fibrillation. They were either sacrificed with a po-
tassium chloride injection (KCl) after 0, 5, 20 or 30 min after untreated cardiac arrest (A) or, after 12 min of cardiac arrest and 8 min of cardiopulmonary 
resuscitation (CPR), return of spontaneous circulation (ROSC) was carried out and animals received a saline solution (Rosc groups) or methylene blue 
(MB groups) before sacrifice at 30, 60 and 180 min post-resuscitation (B).
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amers and iScript reverse transcriptase (Bio-Rad Labora-
tories, USA). The qPCR was conducted on the MyiQ
single-colour Real-time PCR detection system (Bio-Rad
Laboratories, USA). Each reaction contained 12.5 μl 2×
IQ SYBR Green Supermix (Bio-Rad Laboratories, USA),
primers and template to total volume of 25 μl. The ther-
mal profile used for amplification was 95°C for 5 min fol-
lowed by 40 cycles of 97°C for 15 sec, 60°C for 15 sec, and
72°C for 15 sec. At the end of the amplification phase, a
melting-curve analysis was carried out on the products
formed. All primers were designed by Beacon Designer
5.10 (Biosoft International, Palo Alto, CA). Table 1 sum-
marizes the information about the primers, including
Genbank accession numbers.
All experiments were performed in triplicates for every
sample and contained negative controls. Results were
evaluated by MyiQ single-colour Real-time PCR detec-
tion system software (Bio-Rad Laboratories, USA). The
expression levels for Hsp22, Hsp27, Hsp40, Hsp70, Hsp72,
Hsp90, rgs2, cart, ndrg2 as well genes similar to dusp1,
ddit3, gadd45b, nfil3, set and dhcr24 mRNA transcripts
were described as the ratios of the targets normalized to
the endogenous reference (sdha) and then the ratios for
fold change relative to the calibrator were obtained. The
calibrator was constituted from brain samples of piglets
belonging to the Ca0 group.
Results
Gene annotation
The Affymetrix porcine genome microarray is minimally
annotated. Approximately 11% of the probe sets on this
array are described with gene names, posing a challenge
to biological interpretation of data. Lack of annotation is
likely due to the limited availability of full-length porcine
cDNA sequence. To gain further information about the
identity and/or function of the selected sequences which
were not associated to a protein name, BLAST sequence-
similarity searches were performed. After careful verifi-
cation of the resulting alignments, probe sets sharing
sequence similarity with known proteins from other spe-
cies were annotated as "similar to". To avoid redundancy,
only gene symbols are mentioned in the text while full
names are used in the figures and tables. Furthermore
genes annotated "similar to" will be considered as sharing
the same function as the gene they were associated with.
Gene expression profiles after untreated CA
We identified 28 transcripts as differentially expressed, of
which, 21 up-regulated and 7 down-regulated (Table 2).
Only 1 gene, similar to SLC30A10 (a zinc transporter)
showed a constant increase (4-fold) from 5 min to 30
min. Another zinc transporter, SLC30A9 was found mod-
estly increased at 30 min (1.5-fold). The other transcripts
were found significantly changed only at 1 time point
with the exception of PITRM1 which was decreased at 5
and 20 min and 2 uncharacterized genes which were up
and down-regulated (both at 20 and 30 min), respectively.
Although most of the regulated transcripts showed only
moderate changes, prealbumin, GNAL and beta-neoen-
dorphin were highly up-regulated at 20 min (more the 10-
fold). Even though this data set was too small to be sub-
mitted to advanced functional analyses, a functional cate-
gory could be assigned for each probe set (see Table 2).
Gene expression profiles after ROSC
Transcriptional changes for Rosc 30, 60 and 180 were
analyzed using Ca0 as baseline. For changes specifically
induced by MB treatment, MB30, 60 and 180 groups were
compared to their corresponding ROSC (with saline)
controls i.e. Rosc 30, 60 and 180, respectively. After gene
filtering, we obtained a final list of 518 probe sets show-
ing significant changes of expression after either ROSC or
MB treatment. Manual annotations gave a total of 317
probe sets (61%) similar to a known protein, 80 (16%)
identified genes and 121 (23%) lacking any sequence sim-
ilarity in any database and therefore called "unknown"
(for a detailed list see Additional file 1).
We reorganized this large data set by performing hier-
archical clustering (see Figure 2). The data set was split
into 9 parts named cluster 1 to 9 varying in size from 2 to
207 genes. The relevance and the relationship between
the clusters was studied using PCA (Figure 3A) and
expression patterns (Figure 3B). The results showed 5 dis-
tinct subsets of transcripts named as cluster 1, 5, 6, 7 and
8 which contained 34, 130, 41, 205 and 99 genes, respec-
tively. Four more diffuse and heterogeneous very small
subsets (4 members or less) were not considered as valid
clusters. Therefore their members were associated to the
main cluster they appeared to be most similar to, based
on the PCA 3D representation. "Clusters" 4 (2 genes) and
9 (3 genes) were grouped with cluster 1 (Figure 4), "clus-
ter" 3 (4 genes) with cluster 8 (Figure 5) and "cluster" 2 (4
genes) with cluster 7 (Figure 6) while cluster 6 (Figure 7)
and cluster 5 (Figure 8) remained unaffected. Relation-
ships between the main clusters were clearly displayed by
the PCA analysis: cluster 8, corresponding to genes up-
regulated after ROSC, opposite to cluster 1 (down-regu-
lated after ROSC) and cluster 7, corresponding to genes
induced by MB, opposite to cluster 5 (decreased by MB)
(see Figure 3A). Cluster 6 represented transcripts with an
early increase of expression after ROSC and was standing
by itself. Annotated genes were classified by functional
category. The results for differentially expressed proteins
after ROSC and by MB treatment, respectively, were
summarized in Figure 9. A search for overrepresented
functional classes within each cluster showed significant
results only for the group formed by cluster 8. In this
group of transcripts induced after ROSC, 6 functionalMartijn and Wiklund BMC Medical Genomics 2010, 3:27
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classes corresponding to response to stress (p < 0.001),
regulation of transferase activity (p = 0.001), regulation of
protein kinase activity (p = 0.001), apoptosis/type I pro-
grammed cell death (p = 0.034), activation of mitogen-
activated protein (MAP) kinase kinase kinase (p = 0.044)
and programmed cell death (p = 0.044) were overrepre-
sented. A list of the processes affected after ROSC and/or
by MB (addressed in the discussion) can be found in
Additional file 2.
Replication of gene expression profiles by RT-qPCR
Validation of differentially expressed genes according to
the microarray results was conducted by RT-qPCR. We
selected genes with different expression patterns and the
Table 1: Sequences of primers used for qRT-PCR
Gene symbol Primer sequence (5'->3') Product GenBank Acc*
sdha Forward: ACTCGCTCCTGGACCTCGTTG 158 bp DQ845177
Reverse: CCTTATGGTTCCGTTCGCAAATCTC
Hsp22 Forward: AGCCCTGGAAAGTGTGTGTC 198 bp AY609863
Reverse: GGGAAAGCGAGGCAAATACTG
Hsp27 Forward: AGGAGCGGCAGGATGAG 100 bp AY574049
Reverse: GACAGGGAGGAGGAGACC
Hsp40 Forward: GACCAGACCTCCAACAACATTC 189 bp AF288820
Reverse: ATCTTTGAACACAACGGGTATGG
Hsp70 Forward: GCTCAGTGGCATACCTC 182 bp X68213
Reverse: CACGAACCATCCTCTCC
Hsp72 Forward: CAACAAGATCACCATCAC 79 bp AY466608
Reverse: CTTCTCCGCCTCCTG
Hsp90 Forward: AACCGCTCTGCTGTCTTC 103 bp U94395
Reverse: GTCGTCCTCATCAATACCAAG
Similar to dusp1 Forward: CAACCACAAGGCGGACATC 200 bp AK232967
Reverse: TGCTCCTCCTCTGCTTCAC
Similar to ddit4 Forward: AGTAAGACAGTTAAGTCAACAGTG 91 bp XM_001925275
Reverse: GCAGCGAGCACACATCC
Similar to gadd45b Forward: GCTGCGATCTGAAGGTC 102 bp AK231760
Reverse: GCCACACGACAGTTCC
Similar to ddit3 Forward: GAACGAACGGCTCAAG 182 bp CK454369
Reverse: TGGCACTGGTAAGAAGG
rgs2 Forward: CCGCCGCAGATCACCACAGAG 133 bp DQ150111
Reverse: CCTGGCTTCCTGACTCACTAACTCC
Similar to nfil3 Forward: GCCCGATCCACTCTCC 112 bp XM_001928870
Reverse: ATGGCTTTGGCTTTAATCC
Similar to set Forward: TGCCTGCCACCACCATC 138 bp BQ598788
Reverse: CCACCAACACGGACTTCTTAC
cart Forward: CTGCTGCTGCTGCTAC 177 bp AF338229
Reverse: CTTCTCATAAATCGGGATACG
Similar to dhcr24 Forward: AGTGTATGGTGTGTG 116 bp CF360734
Reverse: GTTCTGGACAGTAGG
ndrg2 Forward: CCCGTGTTCCCTTTGG 151 bp DQ985169
Reverse: GGTGACTAAGAGCATATCG
*GeneBank accession number at www.ncbi.nlm.nih.govMartijn and Wiklund BMC Medical Genomics 2010, 3:27
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Table 2: Differentially expressed genes after 5 min (Ca5), 20 min (Ca20) and 30 min (ca30) of untreated CA
Regulation Known Function Probe Set Gene Products Fold change
Ca5 Ca20 Ca30
Up Transcription Ssc.9200.1.A1_at similar to ZCCHC12, Zinc finger CCHC 
domain-containing protein 12
1.3 2.1* 1.3
Transcription Ssc.2132.1.S1_a_at similar to RPS6KA5 ribosomal protein 
S6 kinase alpha-5
0.8 2.3* 1.0
Transcription Ssc.22527.1.A1_at similar to homeobox protein PBX3, 
Pre-B-cell leukemia transcription 
factor 3.
0.9 2.5* 1.3
Signal 
transduction
Ssc.14404.1.A1_at HTR2C, 5-hydroxytryptamine 
(serotonin) receptor 2C
1.1 4.6* 1.5
Transport Ssc.640.1.S1_at TTR, Transthyretin (Prealbumin) 27 2789* 2.6
Cation transport Ssc.3850.1.S1_at similar to NNAT, neuronatin 1.4 1.9* 1.4
Potassium 
transport
Ssc.6932.1.A1_at similar to DPP10, inactive dipeptidyl 
peptidase 10
1.3 1.1 1.5*
Zinc transport Ssc.7040.1.A1_at similar to SLC30A9, solute carrier 
family 30 member 9
1.4 1.1 1.5*
Zinc transport Ssc.17849.1.A1_at similar to SLC30A10, solute carrier 
family 30 member 10
4.0* 4.5* 4.7*
Calcium-
mediated 
signalling
Ssc.29371.1.A1_at similar to GNAL guanine nucleotide-
binding protein G(olf) subunit alpha
1.6 16.5* 1.1
Calcium-
mediated 
signalling
Ssc.19549.1.S1_at similar to NECAB1, Neuronal calcium-
binding protein 1
1.5 1.0 2.0*
Calcium-
mediated 
signalling
Ssc.3649.1.A1_at similar to RCAN3 regulator of 
calcineurin 3 (calcipressin-3)
1.1 1.5* 1.0
Opioid peptide Ssc.121.1.S1_at PDYN, Beta-neoendorphin-dynorphin 6.2 14.2* 1.4
Stress response Ssc.7903.1.A1_at similar to HSPA13, Heat shock 70 kDa 
protein 13 (stress 70 protein 
chaperone microsome-associated 60 
kDa protein)
1.3 0.9 2.0*
Neurogenesis Ssc.19425.1.A1_at similar to MAPT, microtubule-
associated protein tau
1.7* 1.0 1.2
Nucleic acid 
metabolism
Ssc.6238.2.S1_at similar to AK3, GTP:AMP 
phosphotransferase mitochondrial 
(adenylate kinase 3)
1.3 1.1 1.7*
Not determined Ssc.12504.1.A1_at similar to protein FAM14A 0.9 2.0* 0.9
Not determined Ssc.30063.1.A1_at unknown 2.4* 1.0 1.0
Not determined Ssc.29510.1.A1_at unknown 1.6 1.4 2.1*
Not determined Ssc.21096.1.S1_at unknown 1.3 3.6* 4.5*
Not determined Ssc.31095.1.A1_at unknown 1.3 2.0* 0.9
Down Transcription Ssc.19152.1.S1_at similar to CPSF7, cleavage and 
polyadenylation specificity factor 7
0.8 0.8 0.6*
Signal 
transduction
Ssc.13752.1.S1_at similar to PIK3R1, 
phosphatidylinositol 3-kinase p85 
regulatory subunit alpha
0.7 0.3* 0.8Martijn and Wiklund BMC Medical Genomics 2010, 3:27
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results showed a good correlation with the findings from
microarrays (Figure 10)
Discussion
Effects of cardiac arrest/global ischemia
Interruption of blood flow after CA limits the delivery of
oxygen and glucose to neurons causing ATP reduction
which has numerous consequences including neurotoxic-
ity, DNA damage, and production of free radicals [23]. In
our model, we found only 28 significantly differentially
expressed transcripts in total after global ischemia.
Among the moderately up-regulated genes, it is notewor-
thy that 7 transcripts affected by ischemia belonged to
ion transport and calcium signalling functions as it is well
known that one of the first consequences of ischemia-
induced apoptosis is a disruption of ionic gradients across
membranes with increase in extracellular potassium and
influx of sodium, chloride and calcium into the cells.
Interestingly our list included 2 zinc transporters:
SLC30A9 (ZNT9) and SLC30A10 (ZNT10). These find-
ings are in line with an earlier study showing that another
member of the SLC30 family, ZNT1, was induced after
transient forebrain ischemia in the Gerbil [24]. The
SLC30 proteins are CDF (cation diffusion facilitatator)
proteins and plasma membrane efflux transporters [25].
The mechanism of transport for many CDF proteins
appears to be via zinc/H + or K + antiports. Therefore,
despite their name, CDF proteins do not serve as diffu-
sion facilitators but rather as secondary active transport-
ers, using the gradient of other ions to drive the transport
of zinc [26]. Identification of ZNT9 and ZNT10 as isch-
emia-induced genes adds therefore to the growing evi-
dence suggesting that the role of zinc efflux transporters
in cellular zinc homeostasis may be particularly impor-
tant in postischemic neuronal death where high levels of
zinc are accumulated by neurons [27].
Effects of ROSC/reperfusion
Cardiac arrest and CPR elicit global brain ischemia and
reperfusion causing immediate and delayed cell death. I/
R injury results in oxidative stress leading to further gen-
eration of free radicals. This in turn activates numerous
major signalling pathways, in particular through changes
in gene expression which influence the survival or death
of the cells.
The use of microarrays has been applied to study the
effects of permanent or transient ischemia on total brain
or distinct regions in rodent models but, to our knowl-
edge, this is the first time that a genome-wide transcript
profiling study is undertaken in porcine brain to study the
effect of I/R. Our results showed that 141 genes were
induced and only 39 were repressed after ROSC. Such an
imbalance between up- and down-regulated genes could
be due to a technical bias. Y et it is in agreement with a
recent report where the authors monitored the genomic
response to global ischemia and reperfusion in the rat
brain and concluded that the ischemia/reperfusion
response of the rat brain is therefore an active process
[28]. A functional analysis of the clusters revealed that
apoptosis/programmed cell death and stress response
(34% of all induced genes) were overrepresented among
the genes up-regulated after ROSC. Among them we
found proteins belonging to the caspase-dependent apop-
totic pathway, p53 and mitogen-activated protein kinase
pathways, playing a pivotal role in stress and apoptosis.
Consistent with findings in rodent, heat shock proteins
are among the most prominently upregulated genes after
the ischemic insult [29,30]. Overall our gene lists are in
line with previous microarray studies monitoring cerebral
ischemic insult [28-34] including proteins such as ICAM-
1, a main actor for the regulation of ischemia-induced
injury since its inhibition induces neuroprotection after I/
R injury [35,36]; VEGFA as a main indicator for brain
ischemia [37]; IFRD1, an early gene stimulating p53 and
up-regulating iNOS after oxidative stress [38]; inducible
HMOX1 and constitutive HMOX2, two rate-limiting
enzymes for the catabolism of the prooxidant heme
[39,40] and CHOP. a main marker of ER stress [41,42].
Effects of MB treatment
One of the responses to cerebral ischemia is an increase
in the production of NO, catalyzed by nitric oxide syn-
thase (NOS) expression. There has been increasing evi-
dence that neuronal nitric oxide synthase (nNOS)-
Signal 
transduction
Ssc.11787.1.S1_at similar to RASSF2, Ras association 
domain-containing protein 2
0.9 0.6* 0.8
Proteolysis Ssc.3063.1.S1_at similar to PITRM1, pitrilysin 
metalloproteinase 1
0.6* 0.6* 0.9
Glucose 
metabolism
Ssc.19476.2.A1_s_at PYGM, Glycogen phosphorylase 0.7 0.8 0.6*
Immune 
response
Ssc.13778.1.S1_at IgG, Immunoglobulin G, heavy chain 0.5 0.8 0.1*
Not determined Ssc.17442.1.S1_at unknown 0.9 0.6* 0.6*
Table 2: Differentially expressed genes after 5 min (Ca5), 20 min (Ca20) and 30 min (ca30) of untreated CA (Continued)Martijn and Wiklund BMC Medical Genomics 2010, 3:27
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Figure 2 Hierarchical cluster analysis of the 518 differentially expressed genes after ROSC with saline (Rosc groups) or MB (MB groups) 
treatment. Each row represents a gene and each column the colour coded mean value of the three animals for each group. Genes with similar ex-
pression patterns are clustered together (dendrogram on the left).Martijn and Wiklund BMC Medical Genomics 2010, 3:27
http://www.biomedcentral.com/1755-8794/3/27
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Figure 3 Principle component analysis (A) and scatter plot of the expression profiles (B) defined by the 9 clusters generated by hierarchical 
clustering. Each cluster can be easily identified by its associated colour.
A
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Figure 4 Hierarchical clustering of three subsets of genes segregating in cluster 1 (A), "cluster" 4 (B) and "cluster" 9 (C) and for which ex-
pression levels decreased after ROSC.Martijn and Wiklund BMC Medical Genomics 2010, 3:27
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Figure 5 Hierarchical clustering of two subsets of genes segregating in cluster 8 (A), "cluster" 3 (B) and for which expression levels in-
creased after ROSC.
A
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Figure 6 Hierarchical clustering of two subsets of genes segregating in cluster 7 (A), "cluster" 2 (B) and for which expression levels were 
induced by MB.
A
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induced NO is an important mediator in ischemic brain
injury [43]. Methylene blue (MB) exerts an antioxidant
effect by binding and inactivating the action of NO [44],
blocking the soluble guanylate cyclase [45] - the primary
receptor for NO - as well as inhibiting Nitric Oxide Syn-
thase (NOS) [46]. Although transcriptional levels of NOS
did not show any changes after treatment by MB in our
study, we have previously reported that NOS enzymes
were regulated by MB at the protein level, in porcine
brain, already after 30 min (Miclescu et al., submitted).
These results concur with the conclusion that NOS
enzymes are preferentially regulated post-transcription-
ally, thus allowing a more rapid adaptation of the enzyme
activity to cellular stress variations [47]. As could be
expected, we identified the sGC transcript in the set of
genes regulated by MB together with HSP90, a chaperone
forming a complex with both sGC and endothelial nitric
oxide synthase (eNOS) for the modulation of NO produc-
Figure 7 Hierarchical clustering of a subset of genes segregating in cluster 6 and for which expression levels were early induced after ROSC.Martijn and Wiklund BMC Medical Genomics 2010, 3:27
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tion [48]. Although the modulation of cGMP/NO path-
w a y  i s  c o n s i d e r e d  t h e  m o s t  s i g n i f i c a n t  e f f e c t  o f  M B ,
recent studies indicate that it has multiple cellular and
molecular targets.
Inhibition of apoptosis
A number of anti-apoptotic genes were found stimulated
by MB. Some of them exert their effect via inhibition of
caspases: DHCR24 (seladin-1), which protects cells from
oxidative stress by reducing caspase 3 activity [49,50];
PIP5K1, decreasing activated caspases [51]; ELAVL4, an
actor in both neuron-specific RNA processing (for exam-
ple protecting p21 mRNA from decay) and inhibition of
mitochondria-dependent apoptosis [52,53]. Others were
identified as antagonists of the MAPK/p53 apoptotic
pathways: RND3, a pro-survival p53 target gene that
inhibits ROCK I-mediated apoptosis in response to stress
and participates to neurite extension [54]; CSDE1, which
Figure 8 Hierarchical clustering of a subset of genes segregating 
in cluster 5 and for which expression levels were early decreased 
after MB treatment.
Figure 9 Functional analysis of genes regulated after ROSC (A) 
and genes affected by MB treatment (B). Proportion of differentially 
expressed genes in different functional categories. One gene can be 
assigned several functions and therefore belong to more than one cat-
egory.
B
Genes regulated by MB
Trafficking 14%
Cytoskeleton 10%
Regulation of 
transcription 17%
Apoptosis  9%
Stress/inflammation 
8%
Cell cycle 5%
Neurogenesis 9%
Neuroprotection 3%
Signal transduction 
6%
Other 19%
Genes regulated after ROSC
Trafficking 7%
Cytoskeleton 4%
Regulation of 
transcription 14%
Apoptosis 14%
Stress/inflammation 
20%
Cell cycle 9%
Neurogenesis 7%
Neuroprotection 6%
Signal transduction 
5%
Other 14%
A
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Figure 10 Real-time qPCR analysis of genes that showed a significant differential expression in the microarray study. The genes were select-
ed based on relevance to ischemia/reperfusion injury pathophysiology. Data are shown as means (fold change) of normalized ratios of three biological 
replicas (y-axis). Error bars represent standard error of the mean (SEM).
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decreases p53/GADD45g/caspase3 transcription [55];
DDB1, a pro-survival p53 target involved in protein deg-
radation [56]; DUSP6, a MAPK phosphatase which inac-
tivates ERK [57]; YWHAZ, which supports cell survival
by antagonizing apoptotic proteins and has a neuropro-
tective role as p38 MAPK inhibitor [58,59]; as well as
CAMK4, a key protein involved in oxidative stress which
promotes neuronal survival and inhibits apoptosis [60].
Although the anti-apoptotic effect of MB appeared to be
mostly caused by stimulation of specific transcripts, the
repression of the following genes participated to the over-
all protective effect of MB: SMARCA4, a chromatin
remodelling factor and an apoptotic p53 target [61]; NEO
which acquires its pro-apoptotic activity when cleaved by
caspases [62]; TMEM49, a stress-induced protein that
promotes formation of intracellular vacuoles involved in
autophagy [63]; SET (I2PP2A) mediating neuronal apop-
tosis [64]; SLC25A6 which participates in the formation
of the permeability transition pore complex (PTPC)
responsible for the release of mitochondrial signals [65];
and SAFB, an apoptosis marker [66].
ER stress
Upon reperfusion after even a short period of transient
global cerebral ischemia, protein synthesis is severely
suppressed [67,68]. Ischemia-induced suppression of
protein synthesis, which is initiated by activation of
kinases phosphorylating the initiation factor 2 (eIF2a),
has been attributed to ER dysfunction [69]. Our results
showed that eIF2AK2 (PKR) one of the kinases that spe-
cifically phosphorylates eIF2a and therefore inhibits
translation [70], was repressed by MB together with
EDEM3, a protein enhancing the ER-associated degrada-
tion (ERAD) [71]. In addition, DNAJB9, an ER chaperone
suppressing cell death and induced by ER stress [72] was
also induced by MB. These results suggest a potential
counteracting effect of MB on the shutdown of transla-
tion by ER stress.
Vesicle transport
Disruption of the cytoskeleton induced by apoptosis
causes a depolymerization of microtubules followed by
Golgi fragmentation and secretory membrane traffic
arrest [73,74]. In the Golgi network, proteins are sorted
and segregated into transport vesicles to be targeted to
subcellular compartments or released such as neu-
rotransmitters. Our observations suggested that vesicle
trafficking might be affected by MB since proteins which
mediate transport between ER and Golgi such as SEC22b,
STX5, KDELR2 and ERGIC1 [75,76,78] and VPS16 and
GGA3 between Golgi and the endosomes [79,80] were
up-regulated. On the other hand, proteins such as:
VAMP3, a vesicle-associated membrane protein involved
in regulating membrane traffic; AP1S2, modulating the
dynamics of the cytoskeleton [81]; and GOSR2 involved
in transport of proteins from the cis/medial-Golgi to the
trans-Golgi network [75]; were down-regulated by MB.
Neurogenesis
Microtubules, a major component of the cytoskeleton
which is damaged by ischemia, are crucial for intracellu-
lar transport and neurogenesis/neural regeneration. For
example, the principle mechanisms involved in neurite
extension and axonal pathfinding rely upon the reorgani-
zation of cytoskeletal elements induced by microtubule-
associated proteins (MAPs) [82]. Our results showed
changes in a number of microtubule-related proteins
induced by MB: GABARAPL1 and MAP1B, two mem-
bers of the MAP family; EXOC5 mediating the targeting
of post-Golgi secretory vesicles and stimulating neurite
outgrowth [83]; NIPA1 regulating synaptic growth and
axonal microtubules [84]; INA, an intermediate filament
protein involved in the morphogenesis of neurons;
CAMK4 and SEMA6A, both involved in regulation of
microtubule dynamics [85-87]; and SEPT11, which regu-
lates microtubule stability through interaction with
MAP4 [88]. In contrast, 2 microtubule subunits, the kine-
sins KIF5A and KLC1, were inhibited by MB. In addition
to stimulation of the microtubule networks, MB induced
proteins important for brain repair or regeneration such
as: BASP1, TM4SF1, NT, SMARCA1 and RND3, which
all promote neurite outgrowth [54,89-92]; RUFY3, a pro-
survival gene implicated in the formation of a single axon
in developing neurons [93]; GMFB which stimulates neu-
ral regeneration; SC4MOL, involved in brain repair [94];
CASK which plays a role in synaptogenesis [95]; as well as
PAFAH1B2, DAB1 and PREX1 involved in brain cell
migration [96-98]. The effect of MB on neurogenesis
included also the inhibition of OLIG2, a repressor of neu-
rogenesis [99] and two axon-guidance regulating pro-
teins, NEO and NFIA [62,100].
Neuroprotection
MB induced genes known to have a neuroprotective
effect such as: CX43, the primary component protein in
astrocytic gap junctions playing multiple roles in the mit-
igation of apoptotic neuronal damage in cerebral isch-
emia[101,102];. THBD, which activates the anti-
inflammatory and cytoprotective activated protein C
(APC) thus leading to promotion of neovascularization
and neurogenesis in the post-ischemic brain [103]; AQP4,
a neuroprotective water-specific channel, osmoreceptor
regulating water flow in central nervous system
[104,105]; and CART, an intriguing peptide which pro-
tects brain from damage both through ERK activation in
ischemic stroke [106] and potential preservation of mito-
chondrial function and prevention of energy failure after
I/R injury [107].
Conclusions
All these findings suggest that MB exerts neuroprotection
by regulation of the expression of soluble guanylate
cyclase and diverse biological processes from inhibition
of apoptosis and reversal of the shutdown of translationMartijn and Wiklund BMC Medical Genomics 2010, 3:27
http://www.biomedcentral.com/1755-8794/3/27
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to restoration of functional cellular trafficking and activa-
tion of brain repair/regeneration genes as well as induc-
tion of critical neuroprotective proteins. Therefore they
support that MB could be a valuable intervention and
should be investigated as a therapeutic agent against neu-
ral damage associated with I/R injury induced by cardiac
arrest.
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